Guijun Guan

Title: Guijun Guan: Innovator in Liver Disease Research

Introduction

Guijun Guan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of liver disease research through his innovative work and patented technologies. His research focuses on the use of gene editing technology to better understand and model liver diseases.

Latest Patents

Guijun Guan holds a patent for the "Use of ZC3H12B gene or protein and method for establishing animal model of liver disease." This patent describes a method that utilizes gene editing technology to target and knockout the zc3h12b gene. The resulting model exhibits various liver lesions, including hepatobiliary duct hyperplasia, hepatocyte steatosis, and fibrosis. Over time, significant fatty liver development is observed, along with local cyst necrosis and lymphocyte infiltration in liver sinusoids. The presence of human tumor markers such as cytokeratin 19 (CK19), smooth muscle actin (SMA), and glypican-3 (GPC3) positive cells has also been detected. This research suggests that ZC3H12B may serve as a treatment target and biomarker for biliary cystadenoma, biliary cystadenocarcinoma, and liver conditions related to these diseases.

Career Highlights

Guijun Guan is affiliated with Shanghai Ocean University, where he conducts his research and develops his innovative ideas. His work has garnered attention for its potential applications in understanding the pathological processes of liver diseases.

Collaborations

Guijun collaborates with Yuyang Chang, contributing to advancements in liver disease research and the development of animal models for further studies.

Conclusion

Guijun Guan's innovative work in liver disease research highlights the importance of gene editing technology in understanding complex medical conditions. His contributions pave the way for future advancements in treatment and diagnosis.